CSIMarket Company Name, Ticker, Customers, else..
 
Insight Molecular Diagnostics Inc   (NASDAQ: IMDX)
 
Price: $3.8400 $-0.08 -2.041%
Day's High: $3.990000009536743 Week Perf: -10.7 %
Day's Low: $ 3.74 30 Day Perf: -23.66 %
Volume (M): 128,108 52 Wk High: $ 8.51
Volume (M$): $ 0 52 Wk Avg: $5.12
Open: $3.86 52 Wk Low: $2.40



 Market Capitalization (Millions $) 141
 Shares Outstanding (Millions) 37
 Employees 58
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -49
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) 2

Business Description


The company is a diagnostics technology firm specializing in molecular diagnostic test kits, primarily for transplanted organ rejection testing. Its products, including the GraftAssure family of assays, support decentralized, in-house testing at hospitals, transplant centers, and laboratories. The company also engages in oncology diagnostics and offers assay development and clinical testing services to life sciences and biotechnology companies.


   Company Address: 2 International Plaza Dr., Suite 510 Nashville 37217 TN
   Company Phone Number: 255-8880   Stock Exchange / Ticker: NASDAQ IMDX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AWHL   -6.46%    
MYGN   -0.31%    
GH   -0.31%    
NTRA   -4.74%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 32.00
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 84.50
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.73
Working Capital Ratio 2
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.12 $
Revenues (TTM) 0.05 $
Cash Flow (TTM) 0.29 $
Cash 0.48 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 28,793
Net Income per Employee (TTM) -851,017
Receivable Turnover Ratio (TTM) 3.85
Inventory Turnover Ratio (TTM) 2.31
Asset Turnover Ratio (TTM) 0.05

Profitability Ratios Current
Gross Margin (MRQ) 65.69 %
Operating Margin (MRQ) -4770.71 %
Net Margin (MRQ) -4711.3 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Insight Molecular Diagnostics Inc's Segments
UNITED STATES    2.51 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.